Related Keywords
ACTIVE
Healthcare & Education
Biotechnology
Company Profile
Enleofen Bio is a biotechnology company that focuses on developing first-in-class antibody therapeutics for the treatment of fibrotic human diseases. Following the breakthrough discovery in the importance of interleukin 11 as a main driver of fibrosis, Enleofen was founded as a spin-out from National Heart Centre Singapore, SingHealth and Duke-NUS Medical School with Series A funding to translate research findings into treatments that will improve and save the lives of millions of patients worldwide.We aim to develop our lead antibodies in clinical trials within a two-year time frame with the goal of creating a drug that can be used to treat multiple diseases for which there are currently no treatment options. You can find out more about Enleofen by visiting our website at https://www.enleofen.com/.
Website
Email
Founded Date
2021-04-19
Company Size
Company Stage
Industry
Healthcare & Education
Technology
Biotechnology
Client Focus
Status
ACTIVE
AN INITIATIVE BY
MINISTRY OF SCIENCE, TECHNOLOGY, AND INNOVATION
POWERED BY:
COSTI MALAYSIA
MINISTRY OF SCIENCE, TECHNOLOGY, AND INNOVATION
Aras 6, Block C5, Kompleks C
Pusat Pentadbiran Kerajaan Persekutuan
62662 Putrajaya
Malaysia
Aras 6, Block C5, Kompleks C
Pusat Pentadbiran Kerajaan Persekutuan
62662 Putrajaya
Malaysia
Science & Technology Division
The ASEAN Secretariat
70A Jalan Sisingamangaraja Jakarta 12110
Phone (+6221) 7262991
70A Jalan Sisingamangaraja Jakarta 12110
Phone (+6221) 7262991
Useful Links
Association of Southeast Asian Nations (ASEAN)
ASEAN Malaysia 2025
ASEAN Access
ASEAN Tariff Finder
ASEAN Intellectual Property Portal
Follow Us
Copyright © 2025 All right reserved.